SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following its earnings report, which highlighted robust EPS and gross margin improvements but also confirmed a strategic pivot to discontinue Model S/X production in favor of aggressively pursuing Optimus robots and AI, leading to strong investor debate over the company's long-term vision and valuation.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing an unprecedented, parabolic surge to new all-time highs, fueled by mounting geopolitical tensions, persistent inflation, and global central bank diversification away from the US dollar. The community is debating whether this gold rush signals a broader shift away from fiat currencies, with many noting its meme-like price action and its outperformance against Bitcoin as key talking points.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending following its earnings report, where robust growth, particularly in cloud services, is being weighed against significant capital expenditures for AI infrastructure. This dynamic has sparked community debate, with many viewing the stock's pullback as an attractive buying opportunity while others express skepticism about the immediate returns on these large-scale investments.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as the community hotly debates a Reuters report, now clarified, which caused a sector-wide dip by implying the U.S. government was retreating from critical mineral price guarantees. MP's swift public statement confirming its existing, binding DoD price protection agreement is fully intact has led to accusations of market manipulation and strong dip-buying.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow ($NOW) is trending following a strong Q4 earnings beat, robust guidance, and the announcement of a $5 billion share repurchase program, alongside a new strategic partnership with OpenAI for AI agent integration. Despite these positive developments, the stock experienced a significant post-earnings sell-off, fueling a debate among investors who point to market manipulation against 

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following recent investor discussions that underscored its pipeline of over $10 billion in AI data center projects and the accelerating rollout of its $1.4 billion Southeast Asia initiative. The community is buzzing with bullish sentiment, focusing on the company's robust AI infrastructure business, potential for a significant re-rating given its small float, and growing institutional interest.

HeyElsa is an AI-powered on-chain execution platform designed to simplify how users and applications interact with crypto and decentralized finance. The platform converts user intent, expressed through natural language or structured inputs, into deterministic on-chain actions such as swaps, bridging, staking, yield optimization, and automated portfolio execution across multiple blockchain networks and protocols.  HeyElsa operates through both a consumer-facing AI Copilot and a business-to-business infrastructure offering, including widgets, SDKs, and agent execution APIs that can be embedded into wallets and applications. The core purpose of the project is to abstract fragmented DeFi interfaces and execution complexity, while maintaining transparency, security, and user control. HeyElsa focuses on real usage, automation, and reliable execution rather than speculative features, aiming to make crypto transactions seamless and operationally efficient.

Elsa

ELSA CRYPTO is garnering significant attention as a newly listed token on Coinbase, fueling community debate over its innovative A.I. and Zero Knowledge Proof utility, while some speculate on imminent profit-taking by early investors.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is actively trending as Big Tech earnings reports create a mixed picture, with Microsoft dipping while Meta surged on strong AI spending plans, intensifying debate between those cheering the market's relentless rally and skeptics warning of unsustainable AI investments and potential manipulation. The Federal Reserve's decision to hold rates steady was largely anticipated, with investors now dissecting commentary for future guidance amidst broader concerns about inflation and the parabolic rise in precious metals.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR CRYPTO is actively trending on the Base network, experiencing increased volume and community enthusiasm for its AI-powered trading and seamless integration within the Coinbase ecosystem, with many discussing its potential to break through key resistance levels.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending amid a sector-wide sell-off sparked by a report suggesting the government is stepping back from critical mineral price floors, yet many in the community believe this is an overreaction given USAR's recent $1.6 billion federal financing deal and its focus on high-value rare earths that may not require such guarantees.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Traders Buy Large Volume of Call Options on Arbutus Biopharma (NASDAQ:ABUS)

Arbutus Biopharma Corporation (NASDAQ:ABUS - Get Free Report) saw some unusual options trading activity on Tuesday. Stock investors purchased 5,605 call options on the stock. This is an increase of...

<ul class="summary-bullets"><li>The verbal ruling was delivered on January 15, without written reasons, the company said.</li><li>The company said it disagrees with the outcome and plans to seek a review by the Enlarged Board of Appeal once the written ruling is issued.</li><li>The company does not expect the ruling to impact outcomes of its patent infringement cases against Moderna.</li></ul>Arbutus Biopharma Corp. (ABUS) stock crashed more than 18% on Friday after the European Patent Office (EPO) revoked its patent following opposition proceedings brought by affiliates of Moderna and Merck.This marked the <a href="https://stocktwits.com/symbol/ABUS">ABUS stock’s</a> biggest intraday decline since July 2020.The verbal ruling was delivered on January 15 without written reasons, Arbutus said. The EPO ruling reverses two earlier decisions that had upheld an amended version of the patent EP 2279254. According to Google Patents, it covers “Novel lipid formulations for nucleic acid delivery.”The company said it disagrees with the outcome and plans to seek a review by the Enlarged Board of Appeal once the written ruling is issued. Arbutus acknowledged that the decision could affect certain European legal actions against Moderna, including a case in Switzerland and a proceeding before the Unified Patent Court in which the patent is being asserted.<a href="https://stocktwits.com/symbol/MRNA">Moderna</a> (MRNA) jumped 7%, while <a href="https://stocktwits.com/symbol/MRK">Merck</a> (MRK) traded 2% lower.<h2 class="st-heading-2">Impact Outside Europe</h2>Arbutus stressed that the revocation was based on the EPO’s “added matter” standard, which does not apply in other jurisdictions.As a result, the company does not expect the ruling to impact the timing or potential outcomes of its patent infringement cases against Moderna in the United States, Japan, or Canada, a separate Unified Patent Court case not involving the patent, or its ongoing litigation against Pfizer and BioNTech in the U.S.<h2 class="st-heading-2">Retail Reaction</h2>Despite the sharp intraday decline, retail sentiment on Stocktwits turned ‘bullish’ from ‘bearish’ amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/ABUS_jpg_f665738876.webp" alt="ABUS.jpg">One user sees the drop as an opportunity to take up fresh positions.<stembedurl>https://stocktwits.com/LS172/message/642060814</stembedurl>One user said it’s all noise and nothing has changed ‘other than the bad headline’.<stembedurl>https://stocktwits.com/EdDwg/message/642040053</stembedurl>The stock has gained around 20% over the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-jfbr-stock-surge-today/cmUlvsnR4B0">Why This Penny Stock Is On Track To Gain For First Time In 10 Sessions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Plug Power said it was impacted by the speed and development of hydrogen economy.

ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?

The European Patent Office revoked its patent following opposition proceedings brought by affiliates of Moderna and Merck.

Equity

Arbutus Biopharma (NASDAQ:ABUS) Shares Gap Down - Here's Why

Arbutus Biopharma (NASDAQ:ABUS) Shares Gap Down - Time to Sell...

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Arbutus Biopharma (NASDAQ:ABUS) Stock Passes Above 200 Day Moving Average - What's Next...

Arbutus (ABUS) Upgraded to Buy: Here's What You Should Know

Arbutus (ABUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Arbutus Biopharma (NASDAQ:ABUS) Shares Up 6% - Still a Buy?

Arbutus Biopharma (NASDAQ:ABUS) Trading 6% Higher - Here's What Happened...

Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving Average - What's Next...

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 6.4% - What's Next?

Arbutus Biopharma (NASDAQ:ABUS) Trading Down 6.4% - Time to Sell...

Arbutus Biopharma Corporation $ABUS Shares Purchased by Two Seas Capital LP

Two Seas Capital LP increased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 10.3% during the 2nd quarter, according to its most recent Form 13F filing with...

Arbutus Biopharma (NASDAQ:ABUS) Given Buy Rating at Chardan Capital

Chardan Capital reiterated a "buy" rating and issued a $5.00 price target on shares of Arbutus Biopharma in a research report on Friday...

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

ABUS
Arbutus Biopharma Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ABUS News

ABUSArbutus Biopharma Corp